ATLASSonoma Pharmaceuticals (SNOA) earnings date: Nov 3, 2026
Sonoma Pharmaceuticals (SNOA) reports earnings for the quarter ended Sep 30, 2026 on Tue, Nov 3, 2026.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on SNOA
| Last price | $1.14 (+3.2%) |
|---|---|
| Normal 1-day range (±1σ) | ±3.8% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Sonoma Pharmaceuticals stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Sonoma Pharmaceuticals reports on Nov 3, 2026. One email the day before, with ATLAS’s read on Sonoma Pharmaceuticals. You can switch it off at any time.
Alert me before SNOA reportsFree to start. Creating an account takes under a minute.
Notify me when Sonoma Pharmaceuticals reports
Track SNOA free Add Sonoma Pharmaceuticals to a free ATLAS watchlist and see its next report date in one place.
SNOA earnings at a glance
| Next report (confirmed) | Tue, Nov 3, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| Last report | Jul 23, 2026 · Beat |
| Beat rate (last 4 reports) | 2 of 4 (50%) |
| Average EPS surprise | -7.5% |
| Average move around a report | ±1.5% (last 4) |
| Sector | Healthcare · Drug Manufacturers - Specialty & Generic |
Sonoma Pharmaceuticals earnings history: last 4 reports
Sonoma Pharmaceuticals last reported on Jul 23, 2026: EPS of $3.52 against an estimate of $3.32 (+6.0% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Jul 23, 2026 | $3.32 | $3.52 | +6.0% | Beat | -1.7% |
| Mar 13, 2026 | $0.05 | $0.07 | +40.0% | Beat | -1.6% |
| Feb 10, 2026 | -$0.29 | -$0.48 | -65.5% | Miss | -2.1% |
| Jan 17, 2026 | $0.38 | $0.34 | -10.5% | Miss | -0.6% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for SNOA
See the fair value, the probability range and the earnings history of Sonoma Pharmaceuticals on its ATLAS page.
Sonoma Pharmaceuticals (SNOA) stock analysisPlans from €3.99 a month.
Sonoma Pharmaceuticals earnings: frequently asked questions
When does Sonoma Pharmaceuticals (SNOA) report earnings?
Sonoma Pharmaceuticals is scheduled to report on Tuesday, November 3, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
How often does SNOA beat earnings estimates?
Of its last 4 reports with a recorded result, Sonoma Pharmaceuticals beat the EPS estimate 2 times; the average surprise was -7.5%. Past results do not predict the next one.
How much does SNOA move around earnings?
Over its last 4 reports the stock moved an average of 1.5% (absolute, from the close before the report day to the close after it), and finished higher 0 of 4 times.
Did Sonoma Pharmaceuticals beat earnings estimates last quarter?
Sonoma Pharmaceuticals last reported on Jul 23, 2026: EPS of $3.52 against an estimate of $3.32 (+6.0% surprise), a beat.
How much does SNOA usually move in a day?
On a normal trading day the ATLAS model puts SNOA’s one-day range at about ±3.8%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Tue, Nov 3, 2026
Educational information, not investment advice. Disclaimer